Drug class
Complement Inhibitor
Mechanism of action
Complement Inhibitors [MoA]
General use cases
- Hemoglobinuria, Paroxysmal
- Myasthenia Gravis
- Atypical Hemolytic Uremic Syndrome
- patients with Shiga toxin E
- patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
